UEG 2020

2020-10-11 - 2020-10-13
Online, Virtual

ECCO 2020

2020-02-12 - 2020-02-15
Vienna, Austria

AASLD 2018

2018-11-09 - 2018-11-13
San Francisco, CA, United States

AASLD 2017

2017-10-20 - 2017-10-24
Washington DC, United States

WCOG at ACG 2017

2017-10-13 - 2017-10-18
Orlando, United States

UEG 2016

2016-10-15 - 2016-10-19
Vienna, Austria

UEG 2015

2015-10-24 - 2015-10-28
Barcelona, Spain

Gastroupdate 2015

2015-06-12 - 2015-06-13
Budapest, Hungary
Search in Scientific Content:
Date
Filters:
Allergy-re
7:48

Allergy-related diseases and IBS

Presenter: Jessica Sjolund
UEG 2020
Transmural
4:50

Transmural healing in IBD

Presenter: Subrata Ghosh
Specialty: Inflammatory Bowel Diseases
ECCO 2020
A Next-Gen
3:06

A Next-Generation, Dual-Action Anti-Integrin Therapy for IBD

Presenter: David Rubin
Specialty: Inflammatory Bowel Diseases
ECCO 2020
How to seq
2:20

How to sequence advanced therapies in IBD - Evidence from clinical trials and real-world experience

Presenter: Stefan Schreiber
Specialty: Inflammatory Bowel Diseases
ECCO 2020
EUS guided
2:55

EUS guided liver biopsy

Presenter: Kenneth Chang
AASLD 2018
Endoscopic
5:55

Endoscopic measurement of portal vein pressure

Presenter: Kenneth Chang
AASLD 2018
Hepatic Sa
3:54

Hepatic Safety Overview of Obeticholic Acid for the Treatment of Patients with Primary Biliary Cholangitis

Presenter: Paul J. Pockros
AASLD 2018
Control St
3:21

Control Study: Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Patients with Nonalcoholic Steatohepatitis

Presenter: Paul J. Pockros
AASLD 2018
Real Life
5:08

Real Life Rates of Sustained Virological Response Of Sofosbuvir/Velpatasvir Treatment in HCV Genotype GT 1-2-3-4-6

Presenter: Alessandra Mangia
AASLD 2018
Acute Auto
7:22

Acute Autoimmune Hepatitis: Steroids and Timing of Liver Transplant

Presenter: Rodrigo Liberal
AASLD 2018
Non-Invasi
3:04

Non-Invasive Assessment of Fibrosis: Are We There Yet?

Presenter: Richard K. Sterling
AASLD 2018
Risk of He
4:35

Risk of Hepatitis C transmission from antibody positive-nucleic acid negative liver organs to antibody negative recipients

Presenter: Khurram Bari
AASLD 2017
Impact of
4:58

Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality and Hepatocellular Carcinoma

Presenter: Pamela S. Belperio
AASLD 2017
Acute live
6:11

Acute liver injury due to immunotherapy for metastatic cancer: a new challenge

Presenter: Eleonora De Martin
AASLD 2017
Improved S
4:26

Improved Short-Term Survival in HCV Patients following Liver Transplantation in the Era of Direct Acting Antiviral Agents

Presenter: George Cholankeril
AASLD 2017
Integrated
3:51

Integrated Efficacy and Safety of Glecaprevir/Pibrentasvir to Treat HCV Genotype 1-6 Infection in Patients Without Cirrhosis Including HIV Co-Infection

Presenter: David E. Bernstein
AASLD 2017